EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Jane Pei-Chen Chang, Ping-Tao Tseng, Bing-Syuan Zeng, Cheng-Ho Chang, Huanxing Su, Po-Han Chou, Kuan-Pin Su

Advances in Nutrition · 2023-11 · 14 (6) · 1326-1336

DOI: 10.1016/j.advnut.2023.08.003 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Advances in Nutrition, 2023-11. Verfasst von Jane Pei-Chen Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, China Medical University, Taichung, Taiwan; Department of Psychiatry & Mind-Body Interface Laboratory (MBI-Lab), China Medical U…. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, National Science and Technology Council, Tainan Municipal An-Nan Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is no comprehensive review of the evidence to support omega-3 polyunsaturated fatty acids (PUFAs) as a relatively safe and tolerable intervention. This study aimed to provide a meta-analytic and comprehensive review on the adverse effects of all kinds of ω-3 PUFA supplementation reported in randomized controlled trials (RCTs) in human subjects. A systematic review of RCTs published between 1987 and 2023 was carried out based on searches of 8 electronic databases. All RCTs that compared the adverse effects of ω-3 PUFAs containing eicosapentaenoic acid, docosahexaenoic acid, or both compared with controls (a placebo or a standard treatment) were included. The primary outcome was the adverse effects related to ω-3 PUFA prescription. A total of 90 RCTs showed that the ω-3 PUFA group, when compared with the placebo, had significantly higher odds of occurrence of diarrhea (odds ratio [OR] = 1.257, P = 0.010), dysgeusia (OR = 3.478, P < 0.001), and bleeding tendency (OR = 1.260, P = 0.025) but lower rates of back pain (OR = 0.727, P < 0.001). The subgroup analysis showed that the prescription ω-3 PUFA products (RxOME3FAs) had higher ω-3 PUFA dosages than generic ω-3 PUFAs (OME3FAs) (3056.38 ± 1113.28 mg/d compared with 2315.92 ± 1725.61 mg/d), and studies on RxOME3FAs performed more standard assessments than OME3FAs on adverse effects (63% compared with 36%). There was no report of definite ω-3 PUFA-related serious adverse events. The subjects taking ω-3 PUFAs were at higher odds of experiencing adverse effects; hence, comprehensive assessments of the adverse effects may help to detect minor/subtle adverse effects associated with ω-3 PUFAs. This study was registered at PROSPERO as CRD42023401169.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, Omega-3HumansRandomized Controlled Trials as TopicEicosapentaenoic AcidFatty Acids, UnsaturatedDietary Supplements

Stichwörter der Autor:innen

adverse effectdocosahexaenoic acid (DHA)eicosapentaenoid acid (EPA)prescription ω-3 PUFA products (RxOME3FAs)tolerabilityω-3 polyunsaturated fatty acids (PUFAs)

Substanzen

Fatty Acids, Omega-3Eicosapentaenoic AcidFatty Acids, Unsaturated

Autor:innen und Institutionen

  • College of Medicine, China Medical University, Taichung, Taiwan; Department of Psychiatry & Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan.
  • Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; WinShine Clinics in Specialty of Psychiatry, Kaohsiung, Taiwan; Department of Psychology, College of Medical and Health Science, Asia…
  • Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; Department of Internal Medicine, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.
  • Department of Psychiatry, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Department of Food Science, National Pingtung University of Science and Technology, Pingtung, Taiwan.
  • State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
  • Department of Psychiatry & Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan; Department of Psychiatry, China Medical University Hsinchu Hospital, China Medical University, Ta…

Förderung

  • Ministry of Education
  • National Science and Technology Council
  • Tainan Municipal An-Nan Hospital
  • China Medical University Hospital
  • Ministry of Science and Technology, Taiwan
  • Kaohsiung Veterans General Hospital
  • China Medical University, Taiwan

Zitieren

APA

Chang, J. P., Tseng, P. T., Zeng, B. S., Chang, C. H., Su, H., Chou, P. H., & Su, K. P. (2023). Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Advances in Nutrition, 14(6), 1326-1336. https://doi.org/10.1016/j.advnut.2023.08.003

Vancouver

Chang JP, Tseng PT, Zeng BS, Chang CH, Su H, Chou PH, et al. Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Advances in Nutrition. 2023;14(6):1326-1336. doi:10.1016/j.advnut.2023.08.003

BibTeX
@article{Chang2023,
  author = {Chang, Jane Pei-Chen and Tseng, Ping-Tao and Zeng, Bing-Syuan and Chang, Cheng-Ho and Su, Huanxing and Chou, Po-Han and Su, Kuan-Pin},
  title = {Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  journal = {Advances in Nutrition},
  year = {2023},
  volume = {14},
  number = {6},
  pages = {1326--1336},
  doi = {10.1016/j.advnut.2023.08.003}
}
Kostenlos starten →